SGMO
SGMO
$4.61
*
0.09
negative
1.99%

*Data as of May 25, 2012   | Sangamo BioSciences, Inc. | Industry: Health Care | HQ: California, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

 Save stocks for next time
 |  Sponsored

SGMO News Headlines

Share |


   


Sangamo Biosciences To Participate In BofA Merrill Lynch Conference At 5:20 PM
5/16/2012 3:03:00 PM - RTT News

Sangamo Biosciences To Present At JMP Conference; Webcast At 6:00 PM ET
5/14/2012 3:00:00 PM - RTT News

Revenues Rise at Shire - Analyst Blog
4/27/2012 3:50:23 PM - Zacks.com

Sangamo To Present At Biotech Industry Conference; Webcast At 1:30 PM ET
4/20/2012 12:31:00 PM - RTT News

Shire to Buy Pervasis Therapeutics - Analyst Blog
4/18/2012 5:49:24 PM - Zacks.com

Big Profits in Microcaps that Measure Up
4/12/2012 1:29:54 PM - Josh Levine

Sangamo To Present At Needham Healthcare Conference; Webcast At 8:40 AM ET
4/4/2012 7:44:00 AM - RTT News

Shire to Buy FerroKin BioSciences - Analyst Blog
3/22/2012 5:22:27 PM - Zacks.com

7 Stocks In The Healthcare Space Reversing Their Short-Term Bearish Trends
2/21/2012 12:03:00 AM - Seeking Alpha

20 Biotech Stocks That Hedge Funds Are Selling
12/11/2011 2:13:00 AM - Seeking Alpha

Progenics Pharmaceuticals Jumped
12/1/2011 4:21:00 PM - Seeking Alpha

Biologic Drugs: A Fast Growing Industry In The Making
11/30/2011 7:46:00 AM - Seeking Alpha

11 Biotech Stocks With Bullish Short Trends
11/23/2011 10:52:00 AM - Seeking Alpha

20 Biotech Stocks With Strong Corporate Governance
10/5/2011 3:37:00 AM - Seeking Alpha

Buy And Sell Ideas From Monday's Big News Movers
10/4/2011 10:57:00 AM - Seeking Alpha

Monday Options Recap
10/3/2011 3:45:00 PM - Seeking Alpha

Sangamo Neuropathy Drug Failed to Meet Goal in Mid-Stage Trial
10/3/2011 10:57:00 AM - Fox Business

Sangamo's Phase II Results To Be Announced Monday - Expect Good News
10/2/2011 7:36:00 AM - Seeking Alpha

The Wisdom Of The Crowds And Sangamo's Phase II B Clinical Trial Results
9/28/2011 2:19:00 AM - Seeking Alpha

Sangamo's Late Breaking News: Time To Act
9/19/2011 4:31:00 AM - Seeking Alpha

Sangamo's Late Breaking, Game Changing News At ICAAC
9/1/2011 2:59:00 PM - Seeking Alpha

Sangamo BioScience: A Real Bargain Below $5
8/10/2011 12:25:00 PM - Seeking Alpha

Sangamo: An Introduction to Its Gene Altering Technology
8/3/2011 6:53:00 PM - Seeking Alpha

Sangamo's Inevitable Acquisition/Merger
5/22/2011 3:20:00 PM - Seeking Alpha

Sangamo Biosciences's Game Changing Technology
4/20/2011 8:06:00 AM - Seeking Alpha